Roche and Pfizer join «Addplan DF» Consortium

Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, based in Ireland, has announced that Pfizer and Roche have joined the «Addplan DF» Consortium. In 2013, the consortium was founded by Novartis, Janssen Pharmaceuticals, Eli Lilly and Aptiv Solutions, an Icon company leading the design and implementation of adaptive trials. The goal of the Consortium is to develop methodologies and execution technologies that improve dose-selection - a major barrier to resolving high failure rates in Phase III trials, the press release states. Addplan is a fully validated statistical design, simulation and analysis software for adaptive clinical trials widely used by regulatory agencies and the pharmaceutical and medical device industries. The complete press release of Icon The homepage of Icon
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.

Register


Login

Your Benefits

  • Access to all content
  • Receive newsmails for news and jobs
  • Post ads

myScience